CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $958.63M, above the global median of $520.53M
- FinancialsAltman Z-Score 3.03: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.74%Below 5Y avg (1.22%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
17.9%Sustainable
Last Ex-Dividend
Jul 7, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.99BCNY1.04B · vs all stocks (USD)
Trailing P/E
51.38xRevenue (TTM)
6.45BCNY958.63M · vs all stocks (USD)
Profit Margin
2.04%Beta
0.2130xvs all stocks
52-Week Change
-11.15%vs all stocks
Market Capitalization
6.99BCNY1.04B · vs all stocks (USD)
Enterprise Value
7.07BCNY1.05B · vs all stocks (USD)
Trailing P/E
51.38xForward P/E
30.36xPrice to Sales (TTM)
1.06xPrice to Book (MRQ)
1.20xEnterprise to Revenue
1.09xEnterprise to EBITDA
16.96xGross Margin
18.93%Profit Margin
2.04%Operating Margin
6.16%Return on Assets (TTM)
0.46%Return on Equity (TTM)
2.24%Revenue (TTM)
6.45BCNY958.63M · vs all stocks (USD)
Revenue per Share (TTM)
6.32CNYUpdated Aug 20, 2026Quarterly Revenue Growth
19.90%Gross Profit (TTM)
1.11BCNY165.08M · vs all stocks (USD)
EBITDA (TTM)
227.84MCNY33.84M · vs all stocks (USD)
Net Income (TTM)
131.48MCNY19.53M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-62.20%Operating Cash Flow (TTM)
1.16BCNY172.35M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
771.77MCNY114.62M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0510CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.74%vs all stocks
5-Year Average Dividend Yield
1.22%vs all stocks
Payout Ratio
17.86%Minority Interest (Equity)
889.37MCNYFY2025 · Dec 31, 2025Revenue
6.20BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
5.12BCNYFY2025 · Dec 31, 2025Gross Profit
1.09BCNYFY2025 · Dec 31, 2025Operating Income
66.90MCNY9.94M · vs all stocks (USD)
Pre-tax Income
217.87MCNYFY2025 · Dec 31, 2025Income Tax Expense
41.63MCNYFY2025 · Dec 31, 2025Net Income
176.24MCNYFY2025 · Dec 31, 2025EBIT
246.90MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
518.06MCNYFY2025 · Dec 31, 2025Research & Development
152.78MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
263.20MCNYFY2025 · Dec 31, 2025Other Operating Expenses
46.30MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.67MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
29.03MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.1678CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.1678CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.02BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.02BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
176.24MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-4.92MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
737.44MCNYFY2025 · Dec 31, 2025Free Cash Flow
626.68MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.87BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
176.24MCNYFY2025 · Dec 31, 2025Other Non-cash Items
34.40MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
537.41MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-10.61MCNYFY2025 · Dec 31, 2025Capital Expenditures
-110.76MCNYFY2025 · Dec 31, 2025Net Acquisitions
-8.34MCNYFY2025 · Dec 31, 2025Purchase of Investments
-241.40MCNYFY2025 · Dec 31, 2025Sale of Investments
45.78MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-314.72MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
801.39MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-740.17MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-49.30MCNYFY2025 · Dec 31, 2025Other Financing Charges
67.27MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
79.18MCNYFY2025 · Dec 31, 2025Shares Outstanding
1.02BSharesUpdated Aug 20, 2026Float Shares
499.88MSharesUpdated Aug 20, 2026% Held by Insiders
53.87%vs all stocks
% Held by Institutions
4.48%vs all stocks
Total Cash (MRQ)
1.90BCNY281.70M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.86CNYUpdated Aug 20, 2026Total Debt (MRQ)
1.24BCNY183.53M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1873xCurrent Ratio (MRQ)
1.73xBook Value per Share (MRQ)
5.57CNYUpdated Aug 20, 2026Total Assets
9.35BCNY1.39B · vs all stocks (USD)
Total Current Assets
4.30BCNYFY2025 · Dec 31, 2025Total Liabilities
2.79BCNYFY2025 · Dec 31, 2025Total Non-current Assets
5.05BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
339.10MCNYFY2025 · Dec 31, 2025Total Current Liabilities
2.45BCNYFY2025 · Dec 31, 2025Cash
1.87BCNYFY2025 · Dec 31, 2025Cash Equivalents
6.34MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.87BCNYFY2025 · Dec 31, 2025Other Short-term Investments
351.47MCNYFY2025 · Dec 31, 2025Accounts Receivable
719.32MCNYFY2025 · Dec 31, 2025Inventory
942.65MCNYFY2025 · Dec 31, 2025Accounts Payable
947.93MCNYFY2025 · Dec 31, 2025Short-term Debt
745.53MCNYFY2025 · Dec 31, 2025Other Current Liabilities
28.95MCNYFY2025 · Dec 31, 2025Long-term Debt
300.70MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
3.55MCNYFY2025 · Dec 31, 2025Common Stock (Book)
1.02BCNYFY2025 · Dec 31, 2025Retained Earnings
3.58BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
6.56BCNY974.32M · vs all stocks (USD)
52-Week Low
5.76CNYUpdated Aug 20, 202652-Week High
9.03CNYUpdated Aug 20, 202652-Week Change
-11.15%vs all stocks
Beta
0.2130xvs all stocks
50-Day MA
6.41CNYUpdated Aug 20, 2026200-Day MA
7.42CNYUpdated Aug 20, 2026Avg 10-Day Volume
6.26MSharesUpdated Aug 20, 2026Avg 30-Day Volume
7.35MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.1300CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Close Below 40W SMA With Profitability
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.03: safe zoneNotable
Altman Z-Score: 3.03
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $958.63M, above the global median of $520.53MNotable
Revenue (USD): 958,629,007.954Global Median: 520,528,949.311
Levered free cash flow is $114.62M, above the global median of $16.24MNotable
Levered free cash flow (USD): 114,623,677.245Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Xiangyu Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Yahong Meditech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Suzhou Highfine Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Cronos Group Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Medincell SA
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Aidea Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhejiang Ausun Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Zylox-Tonbridge Medical Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Shanghai Haohai Biological Technology Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Avalo Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Anbio Biotechnology Limited
1 interpretationClose Below 40W SMA With Profitability
Shanghai Mechanical and Electrical Industry Co., Ltd.
1 interpretationClose Below 40W SMA With Profitability
Jiajiayue Group Co., Ltd.
1 interpretationClose Below 40W SMA With Profitability